Improving Cancer Treatments with Immunotherapy
Cancer Immunotherapy
['FUNDING_P30'] · STANFORD UNIVERSITY · NIH-11099832
This program works to discover new and better ways to use your body's immune system to fight cancer.
Quick facts
| Phase | ['FUNDING_P30'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STANFORD UNIVERSITY (nih funded) |
| Locations | 1 site (STANFORD, UNITED STATES) |
| Trial ID | NIH-11099832 on ClinicalTrials.gov |
What this research studies
This program brings together experts to better understand how the immune system interacts with cancer. They are developing and using advanced technologies to study immune responses in great detail. The goal is to quickly move promising discoveries from the laboratory to patients, and then use insights from patient experiences to further improve treatments. This includes creating new cell therapies and finding ways to overcome when cancer stops responding to immune treatments.
Who could benefit from this research
Good fit: Patients with various types of cancer who might benefit from new or improved immunotherapy approaches could be ideal candidates for future related clinical opportunities.
Not a fit: Patients whose cancer does not respond to immune-based therapies or who have conditions that prevent immunotherapy may not directly benefit from these specific approaches.
Why it matters
Potential benefit: If successful, this work could lead to more effective and personalized immunotherapy options for various cancers.
How similar studies have performed: This program builds upon existing knowledge in immunology and cancer, with members having already made significant advancements in understanding immune responses and developing new technologies.
Where this research is happening
STANFORD, UNITED STATES
- STANFORD UNIVERSITY — STANFORD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MACKALL, CRYSTAL — STANFORD UNIVERSITY
- Study coordinator: MACKALL, CRYSTAL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.